Reuters on MSN

US FDA rejects AstraZeneca's easy-to-use version of lupus drug Saphnelo

Feb 3 (Reuters) - AstraZeneca said on Tuesday the U.S. health regulator has rejected its application for a self-injectable ...

US FDA rejects AstraZeneca's application for lupus drug to be given under the skin

Anglo-Swedish drumaker AstraZeneca said on Tuesday that the U.S. Food and Drug Administration has declined to approve its ...

Top Pharmaceutical API Manufacturer Navigates Shifts in Global Drug Supply and Regulatory Landscape

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Chia seeds sold at Target and Whole Foods recalled over dangerous contamination risk

Chia seeds sold at Target, Whole Foods Market and on Amazon have been recalled because they may be contaminated with ...

Daily Green Supplement Recall Expands Amid Reports of Salmonella Infections and Hospitalizations

If you take a daily greens supplement, check the label. Why Not Natural of Houston, Texas, is recalling its Why Not Natural ...

US FDA declines to approve Aquestive's oral drug for allergic reactions

By Padmanabhan Ananthan Feb 2 (Reuters) - Aquestive Therapeutics said on Monday the U.S. FDA has declined to approve its oral ...

AstraZeneca stock falls after FDA rejects lupus drug injection form

Investing.com -- AstraZeneca PLC (ST:AZN) stock fell 1.5% in Tuesday morning trade after the U.S. Food and Drug ...

Policymakers And Lawmakers Eyeing New Regulations To Restrict Monetization Of AI Mental Health Chats

AI makers can monetize your AI mental health chats and pretty much do so without crossing a legal line. Here's the insight.

MoonLake Announces FDA Fast Track Designation for Sonelokimab Palmoplantar Pustulosis (PPP) and Provides Details on Upcoming Investor Day

The Dermatology Division of the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to sonelokimab (SLK) in moderate-to-severe palmoplantar pustulosis (PPP) supported by ...

FDA rejects self-injected version of AstraZeneca’s lupus drug

The US Food and Drug Administration rejected a subcutaneous version of AstraZeneca Plc’s lupus medicine that would make it easier to administer.
Marijuana Moment

West Virginia And Mississippi Lawmakers Approve Psychedelics Bills To Fund Ibogaine Trials Toward FDA Approval

The West Virginia House of Delegates and Mississippi House of Representatives have both approved bills to support research in ...

DeSantis’ Canadian drug import plan in Florida goes from campaign trail to tough realities

The state’s effort has stalled in part because it failed to win over the Canadian drug industry, which has consistently warned the Canadian government that the U.S. program jeopardized the country’s ...